Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perhexiline for Cardiac Energetic Impairment in Diabetes
NCT00628056Phase 2Unknown
- Sponsor
- University Hospitals Birmingham
- Start
- Oct 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in diabetic cardiomyopathy (DCM) comparing Perhexiline with Placebo (2 arms). Primary endpoint: Change in cardiac PCr/ATP ratio at 2 weeks. Status: unknown.
02
Drugs
perhexiline
03
Conditions
diabetic cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT00628056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00628056.